Cardiovascular Disorders and Epigenetics

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cardiovascular disease is the leading cause of death worldwide. With the continuous increase in the prevalence and incidence of cardiovascular disorders, it has become imperative to understand more in depth their pathophysiology and search for novel biomarkers and therapies. Epigenetics refers to the heritable changes in gene expression that are not caused by the DNA sequence itself. Mounting evidence suggests that cardiovascular risk factors such as hypertension, diabetes, obesity, and smoking are associated with changes of epigenetic components. Additionally, these risk factors may trigger modifications within the epigenome, affecting the expression of several genes and inducing cardiac pathologies such as atherosclerotic disease, heart failure, and hypertrophic cardiomyopathy. Emerging experimental data are showing that epigenetic-modifying agents can reverse some pathological cardiovascular conditions. However, it is still unknown whether these approaches will be successfully translated into cardiovascular drugs.

Original languageEnglish
Title of host publicationMedical Epigenetics
PublisherElsevier Inc.
Pages243-256
Number of pages14
ISBN (Electronic)9780128032404
ISBN (Print)9780128032398
DOIs
Publication statusPublished - 1 Jul 2016
Externally publishedYes

Fingerprint

Epigenomics
Cardiovascular Agents
DNA sequences
Biomarkers
Pathology
Medical problems
Mountings
Gene expression
Gene Expression
Genes
Hypertrophic Cardiomyopathy
Cause of Death
Cardiovascular Diseases
Heart Failure
Obesity
Smoking
Hypertension
Incidence
Therapeutics

Keywords

  • Atherosclerosis
  • Cardiology
  • Cardiovascular disease
  • Coronary artery disease
  • DNA methylation
  • Epigenetics
  • Heart failure
  • Hypertrophic cardiomyopathy
  • Ischemic heart disease
  • Stroke

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Cardiovascular Disorders and Epigenetics. / Abi Khalil, Charbel.

Medical Epigenetics. Elsevier Inc., 2016. p. 243-256.

Research output: Chapter in Book/Report/Conference proceedingChapter

Abi Khalil, Charbel. / Cardiovascular Disorders and Epigenetics. Medical Epigenetics. Elsevier Inc., 2016. pp. 243-256
@inbook{66627a39961144d18ee84cda001fb124,
title = "Cardiovascular Disorders and Epigenetics",
abstract = "Cardiovascular disease is the leading cause of death worldwide. With the continuous increase in the prevalence and incidence of cardiovascular disorders, it has become imperative to understand more in depth their pathophysiology and search for novel biomarkers and therapies. Epigenetics refers to the heritable changes in gene expression that are not caused by the DNA sequence itself. Mounting evidence suggests that cardiovascular risk factors such as hypertension, diabetes, obesity, and smoking are associated with changes of epigenetic components. Additionally, these risk factors may trigger modifications within the epigenome, affecting the expression of several genes and inducing cardiac pathologies such as atherosclerotic disease, heart failure, and hypertrophic cardiomyopathy. Emerging experimental data are showing that epigenetic-modifying agents can reverse some pathological cardiovascular conditions. However, it is still unknown whether these approaches will be successfully translated into cardiovascular drugs.",
keywords = "Atherosclerosis, Cardiology, Cardiovascular disease, Coronary artery disease, DNA methylation, Epigenetics, Heart failure, Hypertrophic cardiomyopathy, Ischemic heart disease, Stroke",
author = "{Abi Khalil}, Charbel",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/B978-0-12-803239-8.00014-4",
language = "English",
isbn = "9780128032398",
pages = "243--256",
booktitle = "Medical Epigenetics",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Cardiovascular Disorders and Epigenetics

AU - Abi Khalil, Charbel

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Cardiovascular disease is the leading cause of death worldwide. With the continuous increase in the prevalence and incidence of cardiovascular disorders, it has become imperative to understand more in depth their pathophysiology and search for novel biomarkers and therapies. Epigenetics refers to the heritable changes in gene expression that are not caused by the DNA sequence itself. Mounting evidence suggests that cardiovascular risk factors such as hypertension, diabetes, obesity, and smoking are associated with changes of epigenetic components. Additionally, these risk factors may trigger modifications within the epigenome, affecting the expression of several genes and inducing cardiac pathologies such as atherosclerotic disease, heart failure, and hypertrophic cardiomyopathy. Emerging experimental data are showing that epigenetic-modifying agents can reverse some pathological cardiovascular conditions. However, it is still unknown whether these approaches will be successfully translated into cardiovascular drugs.

AB - Cardiovascular disease is the leading cause of death worldwide. With the continuous increase in the prevalence and incidence of cardiovascular disorders, it has become imperative to understand more in depth their pathophysiology and search for novel biomarkers and therapies. Epigenetics refers to the heritable changes in gene expression that are not caused by the DNA sequence itself. Mounting evidence suggests that cardiovascular risk factors such as hypertension, diabetes, obesity, and smoking are associated with changes of epigenetic components. Additionally, these risk factors may trigger modifications within the epigenome, affecting the expression of several genes and inducing cardiac pathologies such as atherosclerotic disease, heart failure, and hypertrophic cardiomyopathy. Emerging experimental data are showing that epigenetic-modifying agents can reverse some pathological cardiovascular conditions. However, it is still unknown whether these approaches will be successfully translated into cardiovascular drugs.

KW - Atherosclerosis

KW - Cardiology

KW - Cardiovascular disease

KW - Coronary artery disease

KW - DNA methylation

KW - Epigenetics

KW - Heart failure

KW - Hypertrophic cardiomyopathy

KW - Ischemic heart disease

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84988305220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988305220&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-803239-8.00014-4

DO - 10.1016/B978-0-12-803239-8.00014-4

M3 - Chapter

AN - SCOPUS:84988305220

SN - 9780128032398

SP - 243

EP - 256

BT - Medical Epigenetics

PB - Elsevier Inc.

ER -